Metraipolis › archive › dc_56a08fbb8027

Evaluating dosimetric outcomes: a comparison of CyberKnife, VMAT FFF, and Helical Tomotherapy Radixact for treating localized prostate cancer — Europe PMC PMID:40932679

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40932679
DOI
10.1007/s11547-[numero omesso]-3
License (as archived)
solo-consultazione
Archived
2026-11-10T00:36:09.389Z
SHA-256 of the archived text
a11ff787ac5bf7fe31099e314aea721112e5aa658d3b835f698ef5602ecad574
Stable URL of this page
https://metraipolis.com/documento/dc_56a08fbb8027

How to cite

Evaluating dosimetric outcomes: a comparison of CyberKnife, VMAT FFF, and Helical Tomotherapy Radixact for treating localized prostate cancer — Europe PMC PMID:40932679 — Europe PMC (en), https://europepmc.org/article/MED/40932679 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_56a08fbb8027 (Metraipolis archive dc_56a08fbb8027, sha256 a11ff787ac5bf7fe31099e314aea721112e5aa658d3b835f698ef5602ecad574)
BibTeX
@misc{dc56a08fbb8027,
  title = {Evaluating dosimetric outcomes: a comparison of CyberKnife, VMAT FFF, and Helical Tomotherapy Radixact for treating localized prostate cancer — Europe PMC PMID:40932679},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40932679},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_56a08fbb8027; sha256 a11ff787ac5bf7fe31099e314aea721112e5aa658d3b835f698ef5602ecad574},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40932679. Agents can read the archived copy with the MCP tool read_document.